-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Upgrades Fulgent Genetics to Buy, Raises Price Target to $30

Benzinga·08/05/2025 11:19:42
Listen to the news
UBS analyst Lu Li upgrades Fulgent Genetics (NASDAQ:FLGT) from Neutral to Buy and raises the price target from $20 to $30.